Royal Bank of Canada’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-924
| Closed | -$20K | – | 7200 |
|
2024
Q1 | $20K | Sell |
924
-33,595
| -97% | -$727K | ﹤0.01% | 5487 |
|
2023
Q4 | $332K | Buy |
34,519
+30,315
| +721% | +$292K | ﹤0.01% | 4132 |
|
2023
Q3 | $11K | Buy |
4,204
+2,365
| +129% | +$6.19K | ﹤0.01% | 5905 |
|
2023
Q2 | $9K | Sell |
1,839
-364
| -17% | -$1.78K | ﹤0.01% | 6060 |
|
2023
Q1 | $8K | Buy |
2,203
+1,353
| +159% | +$4.91K | ﹤0.01% | 6046 |
|
2022
Q4 | $3K | Hold |
850
| – | – | ﹤0.01% | 6411 |
|
2022
Q3 | $3K | Hold |
850
| – | – | ﹤0.01% | 6453 |
|
2022
Q2 | $2K | Hold |
850
| – | – | ﹤0.01% | 6556 |
|
2022
Q1 | $7K | Hold |
850
| – | – | ﹤0.01% | 6655 |
|
2021
Q4 | $4K | Sell |
850
-1,500
| -64% | -$7.06K | ﹤0.01% | 6761 |
|
2021
Q3 | $19K | Buy |
2,350
+1,200
| +104% | +$9.7K | ﹤0.01% | 6205 |
|
2021
Q2 | $9K | Buy |
1,150
+837
| +267% | +$6.55K | ﹤0.01% | 6417 |
|
2021
Q1 | $3K | Buy |
313
+13
| +4% | +$125 | ﹤0.01% | 6683 |
|
2020
Q4 | $4K | Hold |
300
| – | – | ﹤0.01% | 6202 |
|
2020
Q3 | $4K | Hold |
300
| – | – | ﹤0.01% | 5705 |
|
2020
Q2 | $5K | Buy |
+300
| New | +$5K | ﹤0.01% | 5583 |
|